Pure Eye Muscle Involvement in Endocrine Orbitopathy

We present a long-term follow-up examination concerning patients with isolated extra-ocular muscle involvement in thyroid-related orbitopathy. Within the previous 13 years we observed 7 patients with endocrine orbitopathy and marked myopathy of the extra-ocular muscles. Five of these patients had no detectable proptosis, 2 of them showed a minimal unilateral proptosis. Five patients showed elevated thyroid-stimulating hormone (TSH) receptor auto-antibodies and 6 patients a marked swelling of the extra-ocular eye muscles on CT or MRI scans. One patient had elevated antibodies against thyroid peroxidase and against thyroglobulin and normal TSH receptor auto-antibodies. Four of 7 patients underwent clinical and radiological follow-up examination 1–9 years later. In 3 of these 4 patients, the clinical syndrome had completely resolved. None of the patients had developed any proptosis. The swelling of the eye muscles on radiological imaging had at least partially resolved. We conclude from our results that apart from the frequent subtype of endocrine orbitopathy with predominant proptosis there is a separate subtype in which proptosis neither exists initially nor develops in the further course. Probably these subtypes have a specific immunological antibody profile although they do not differ concerning the thyroid-stimulating antibodies.

[1]  A. Frauman,et al.  TSH receptor protein is selectively expressed in normal human extraocular muscle , 2005, Muscle & nerve.

[2]  P. Chinnery,et al.  Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders , 2005, Neuromuscular Disorders.

[3]  Robert A Goldberg,et al.  Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy. , 2004, American journal of ophthalmology.

[4]  L. Seah,et al.  Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves’ disease differ and suggest ophthalmopathy is a multiantigenic disease , 2004, Clinical endocrinology.

[5]  J. Wall,et al.  Eye muscle antibodies in Graves’ ophthalmopathy: Pathogenic or secondary epiphenomenon? , 2004, Journal of endocrinological investigation.

[6]  M. Nardi,et al.  Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. , 2003, European journal of endocrinology.

[7]  A. Lindner,et al.  Successful treatment of orbital myositis with intravenous immunoglobulins , 1998, Muscle & nerve.

[8]  G. Kahaly,et al.  Endokrine Orbitopathie 1998 , 1998, Medizinische Klinik.

[9]  C. Spitzweg,et al.  Pathogenese der immunogenen Hyperthyreose und endokrinen Orbitopathie , 1998, Der Internist.

[10]  S. Nagataki,et al.  Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance. , 1995, The Journal of clinical endocrinology and metabolism.

[11]  A. Osborn,et al.  Computed tomographic features of nonthyroid extraocular muscle enlargement. , 1989, Ophthalmology.

[12]  A. Weetman,et al.  Graves' disease , 1988 .

[13]  C. Hess,et al.  Okuläre Myositis , 1997, Der Nervenarzt.